The Efficacy and Safety Analysis of Opioid Analgesics in the Treatment of Pain in Elderly Patients with Malignant Tumors and Cancer Pain
Wen-Juan Feng
Abstract
Objective: To investigate the efficacy and safety of opioid analgesics in the treatment of pain in elderly patients with malignant tumors and cancer pain. Methods: 108 cases of malignant tumor patients admitted to our hospital from March 2022 to December 2023 were selected as the research subjects. Opioid analgesics such as codeine, hydrocodone, fentanyl, methadone, tramadol, and morphine were used for analgesia, and the analgesic effect and safety were analyzed. Results: The pain of patients was relieved and improved compared to before treatment, and the differences in the comparison results were statistically significant (P < 0.05). The types of adverse reactions included dizziness, nausea and vomiting, somnolence, respiratory depression, etc. The total incidence rates of adverse reactions with four or more drugs were 11.11%,7.41%, 6.48%, and 8.33%, respectively, and the comprehensive incidence rate of adverse reactions was 47.22%.Conclusion: Analgesic treatment for elderly patients with malignant tumors and cancer pain can be selected according to the category of drugs, which can effectively improve and alleviate the level of pain. However,various adverse reactions are prone to occur, so medication should be used cautiously and appropriate types of drugs should be selected according to the patient's condition.
Keywords
Opioid analgesics; Elderly malignant tumors; Cancer pain; Analgesic treatmentFull Text
PDFReferences
[2] Wen Y, Wei Y, Li X, et al. Sichuan expert consensus on clinical practice norms of patientcontrolled intravenous analgesia technology for cancer pain patients[J]. Cancer Prevention and Treatment, 2024, 37(01): 1-19.
[3] Chang W, Sun Y, Liu Z. Comparison of the effects of hydrocodone and morphine titration-controlled intravenous analgesia on cancer pain patients[J]. Aerospace Medicine, 2024, 35(01): 60-62.
[4] Yang C, Zhu Z, Chen Y, et al. Long-term high-dose hydrocodone PCIA treatment of refractory cancer pain in a patient with advanced osteosarcoma[J]. Chinese Journal of Pain Medicine, 2024, 30(01): 79-80.
[5] Li X, Pan X, Zhao Y, et al. Comparison of opioid demand between Wa and Han cancer pain patients: a single-center retrospective study[J]. China Rational Drug Use Exploration, 2024, 21(01): 87-91.
Copyright © 2024 Wen-Juan Feng Publishing time:2024-02-27
This work is licensed under a Creative Commons Attribution 4.0 International License